As decriminalisation and legalisation of Marijuana are trending in western parts of the world, the Oxford University on Thursday has declared that it will start a research project of £ 10 million on the medicinal profits of marijuana. The research is in alliance with Kingsley Capital Partners, a private equity firm who have researched on cannabinoid to create a global centre of excellence.
The research is completely based on finding medical benefits of the drug and supports the innovative new therapies to help millions of people across the globe.
This initiative comes soon after a member of Britain Parliament called for the legalisation of marijuana. The cannabis used in the research will be received from Europe for the treatment of various diseases. As per findings, the drug has therapeutic properties.
“Medical cannabis and cannabinoid medicine are already helping patients with some of the most distressing conditions across the world,” Neil Mahapatra, one of the managing partners of the firm, told the Financial Times.
“This field holds great promise for developing novel therapeutic opportunities for cancer patients,” Ahmed Ahmed, a professor of Gynaecological Oncology at Oxford University said.
